Concepedia

Angilique Svolto

AS

Statistics

Publications

4

Citations

208

H-Index

4

Active since

2008

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Angilique Svolto is an author at GlaxoSmithKline (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2008–2011

4

Publications

4

Imidazopyridine-5,6,7,8-tetrahydro-8-quinolinamine derivatives with potent activity against HIV-1

Kristjan S. Gudmundsson, Sharon Boggs, John G. Catalano et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 85 citations

, , +10

Advances in two-metal chelation inhibitors of HIV integrase

Brian A. Johns, Angilique Svolto · Expert Opinion on Therapeutic Patents · 2008 · 54 citations

, , +17

Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1

John G. Catalano, Kristjan S. Gudmundsson, Angilique Svolto et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 40 citations

, , +14

Novel 4,4-Disubstituted Piperidine-Based C–C Chemokine Receptor-5 Inhibitors with High Potency against Human Immunodeficiency Virus-1 and an Improved human Ether-a-go-go Related Gene (hERG) Profile

Wieslaw M. Kazmierski, Don L. Anderson, Christopher Aquino et al. · Journal of Medicinal Chemistry · 2011 · 29 citations · Full text

, , +17

1–4 of 4